We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.5B
AUM Growth
+$789M
Cap. Flow
-$527M
Cap. Flow %
-4.21%
Top 10 Hldgs %
24.36%
Holding
3,037
New
13
Increased
378
Reduced
2,598
Closed
33

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$15.8M
2
LULU icon
lululemon athletica
LULU
+$6.87M
3
WPC icon
W.P. Carey
WPC
+$5.99M
4
FND icon
Floor & Decor
FND
+$4.76M
5
BURL icon
Burlington
BURL
+$4.51M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.7M
2
MSFT icon
Microsoft
MSFT
+$34.4M
3
ATVI
Activision Blizzard
ATVI
+$17.1M
4
AMZN icon
Amazon
AMZN
+$16.2M
5
NVDA icon
NVIDIA
NVDA
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Financials 13.04%
3 Healthcare 12%
4 Consumer Discretionary 11.86%
5 Industrials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRAB icon
2926
Grab
GRAB
$14.3B
$6K ﹤0.01%
+1,902
New +$6.15K
IPSC icon
2927
Century Therapeutics
IPSC
$364M
$6K ﹤0.01%
1,883
-210
-10% -$383
KZR
2928
DELISTED
Kezar Life Sciences
KZR
$6K ﹤0.01%
652
-48
-7% -$422
PRPL icon
2929
Purple Innovation
PRPL
$35.3M
$6K ﹤0.01%
218
-24
-10% -$615
SWKH
2930
DELISTED
SWK Holdings
SWKH
$6K ﹤0.01%
416
-46
-10% -$600
VALU icon
2931
Value Line
VALU
$321M
$6K ﹤0.01%
125
-10
-7% -$426
ZVIA icon
2932
Zevia
ZVIA
$122M
$6K ﹤0.01%
2,952
-250
-8% -$501
LENZ
2933
LENZ Therapeutics
LENZ
$166M
$6K ﹤0.01%
349
-40
-10% -$660
CUTR
2934
DELISTED
Cutera, Inc.
CUTR
$6K ﹤0.01%
1,610
-180
-10% -$548
ACET icon
2935
Adicet Bio
ACET
$85.2M
$5K ﹤0.01%
173
-18
-9% -$392
AFRI icon
2936
Forafric Global
AFRI
$289M
$5K ﹤0.01%
456
-53
-10% -$586
ATRA icon
2937
Atara Biotherapeutics
ATRA
$75.5M
$5K ﹤0.01%
373
-39
-9% -$909
BRBS icon
2938
Blue Ridge Bankshares
BRBS
$315M
$5K ﹤0.01%
1,599
-180
-10% -$550
ELA icon
2939
Envela
ELA
$563M
$5K ﹤0.01%
1,075
-76
-7% -$326
GOCO
2940
DELISTED
GoHealth
GOCO
$5K ﹤0.01%
343
-39
-10% -$533
METCB icon
2941
Ramaco Resources Class B
METCB
$425M
$5K ﹤0.01%
428
-50
-10% -$617
OPFI icon
2942
OppFi
OPFI
$800M
$5K ﹤0.01%
974
-98
-9% -$312
RLYB icon
2943
Rallybio
RLYB
$84.5M
$5K ﹤0.01%
274
-21
-7% -$513
SST icon
2944
System1
SST
$14.3M
$5K ﹤0.01%
216
-25
-10% -$370
TRVI icon
2945
Trevi Therapeutics
TRVI
$2.59B
$5K ﹤0.01%
3,631
-418
-10% -$633
UHG
2946
DELISTED
United Homes Group
UHG
$5K ﹤0.01%
536
-62
-10% -$432
VATE icon
2947
INNOVATE Corp
VATE
$111M
$5K ﹤0.01%
445
-46
-9% -$563
VIGL
2948
DELISTED
Vigil Neuroscience
VIGL
$5K ﹤0.01%
1,402
-161
-10% -$828
WKHS icon
2949
Workhorse Group
WKHS
$33.2M
$5K ﹤0.01%
5
EGRX
2950
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5K ﹤0.01%
948
-117
-11% -$1.16K

Similar funds

Amalgamated Bank's Q4 2023 Portfolio in Review

As of Q4 2023, Amalgamated Bank held 3,037 positions worth $12.5B, up 6.7% from $11.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Amalgamated Bank withdrew a net $527M in Q4 2023, closing 33 positions and reducing 2,598 holdings. Its most notable exit was Activision Blizzard, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Amalgamated Bank opened a new position in Veralto worth $4.58M.

  • Amalgamated Bank's largest Q4 2023 buy was Veralto: 55,654 shares worth $4.58M.
  • Amalgamated Bank added most to Uber in Q4 2023, an estimated $15.8M increase.
  • Amalgamated Bank's biggest Q4 2023 reduction was Apple, cutting an estimated $40.7M.
  • Amalgamated Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $17.1M.
  • Amalgamated Bank's ten largest holdings make up 24% of its $12.5B portfolio in Q4 2023.
  • Amalgamated Bank opened 13 new positions and closed 33 in Q4 2023.
  • Amalgamated Bank's portfolio value rose 6.7% quarter-over-quarter to $12.5B.

Based on Amalgamated Bank's 13F filing for Q4 2023, filed 6 Feb 2024.